Shandong Xinhua Pharmaceutical Co Ltd
Company Profile
Business description
Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates the business through the following segments: Chemical bulk drugs which also generates key revenue, Preparations, Chemical intermediates, and other products. The company provides chemical bulk drug products, including metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, and L-dopa, it also dispenses formulation products such as compound liquorice tablets and nimodipine tablets. Its products address disorders related to the central nervous system and the cerebrovascular system with the help of antipyretics and analgesics. Geographically, the company generates a majority of its revenue from China (including Hong Kong), America, Europe and others.
Contact
No. 1 Lutai Avenue
Hi-tech Industry Development Zone
ZiboShandong255086
CHNT: +86 5332166666
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2024
Employees
7,064
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,708.50 | 46.20 | -0.53% |
CAC 40 | 7,255.42 | 18.53 | 0.26% |
DAX 40 | 20,016.75 | 83.13 | 0.42% |
Dow JONES (US) | 44,705.53 | 76.47 | -0.17% |
FTSE 100 | 8,359.41 | 46.52 | 0.56% |
HKSE | 19,641.62 | 104.70 | -0.53% |
NASDAQ | 19,480.91 | 76.96 | 0.40% |
Nikkei 225 | 39,172.60 | 76.26 | -0.19% |
NZX 50 Index | 12,895.20 | 197.98 | -1.51% |
S&P 500 | 6,049.88 | 2.73 | 0.05% |
S&P/ASX 200 | 8,442.60 | 52.60 | -0.62% |
SSE Composite Index | 3,365.75 | 13.06 | -0.39% |